MORF4L2P1

Across TCGA pan-cancer cohorts, MORF4L2P1 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MORF4L2P1 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MORF4L2P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MORF4L2P1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and STAD show a favorable association.

UCEC, MESO, and KIRC are the cancer types where MORF4L2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.686	0.853	<.001	108	view →
MESO	OS	Tertile	IV	0.077	0.638	<.001	45	view →
KIRC	DFS	Median	II,III,IV	0.719	0.859	.004	43	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	36	view →
KIRP	DFS	Tertile	All	0.821	0.936	.003	30	view →
UVM	DFS	Tertile	All	0.079	0.746	<.001	27	view →
SKCM	OS	Tertile	All	0.458	0.309	.006	26	view →
LGG	OS	Tertile	All	0.313	0.480	.001	21	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
BLCA	OS	Tertile	IV	0.147	0.587	.007	18	view →
LIHC	DFS	Tertile	III,IV	0.150	0.453	.008	15	view →
KICH	OS	Tertile	All	0.432	0.890	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MORF4L2P1–UCEC (DFS)

Open the UCEC breakdown →